Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

CAROLINA CAMACHO

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1457439804
CMS profile
10694929
Location
LOS ANGELES, CA

General Payments · PY2021–2024

$1,474.71

  • Reported across 65 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$366.50

15 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $351.27 14
Travel and Lodging $15.23 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $220.96 8
Acerta Pharma LLC $57.43 3
Novo Nordisk AS $37.24 2
Boehringer Ingelheim Pharmaceuticals, Inc. $26.14 1
PFIZER INC. $24.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $425.61 20
PY2022 $302.89 15
PY2023 $379.71 15
PY2024 $366.50 15

Payment records · PY2024 (15)

Sorted by paying entity, then date · as published by CMS

Program year 2024 202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $20.93 01/30/2024 Food and Beverage Undisputed 01/23/2026 1105727279 CMS
AstraZeneca Pharmaceuticals LP $15.50 05/02/2024 Food and Beverage Undisputed 01/23/2026 1104488602 CMS
AstraZeneca Pharmaceuticals LP $21.00 05/31/2024 Food and Beverage Undisputed 01/23/2026 1105680097 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $26.14 05/16/2024 Food and Beverage Undisputed 01/23/2026 1118016754 CMS
Lilly USA, LLC $121.82 03/28/2024 Food and Beverage Undisputed 01/23/2026 1135589763 CMS
Lilly USA, LLC $15.23 03/28/2024 Travel and Lodging Undisputed 01/23/2026 1135615513 CMS
Lilly USA, LLC $11.04 06/20/2024 Food and Beverage Undisputed 01/23/2026 1135615515 CMS
Lilly USA, LLC $12.08 09/17/2024 Food and Beverage Undisputed 01/23/2026 1135599833 CMS
Lilly USA, LLC $7.22 10/14/2024 Food and Beverage Undisputed 01/23/2026 1135589759 CMS
Lilly USA, LLC $33.65 10/17/2024 Food and Beverage Undisputed 01/23/2026 1135589765 CMS
Lilly USA, LLC $11.46 10/29/2024 Food and Beverage Undisputed 01/23/2026 1135589761 CMS
Lilly USA, LLC $8.46 10/29/2024 Food and Beverage Undisputed 01/23/2026 1135615511 CMS
Novo Nordisk Inc $22.40 02/09/2024 Food and Beverage Undisputed 01/23/2026 1100456030 CMS
Novo Nordisk Inc $14.84 08/16/2024 Food and Beverage Undisputed 01/23/2026 1100621712 CMS
PFIZER INC. $24.73 05/22/2024 Food and Beverage Undisputed 01/23/2026 1132034097 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.